Ankaferd Blood Stopper for Controlling Gastrointestinal Bleeding due to Distinct Benign Lesions Refractory to Conventional Antihemorrhagic Measures
Mevlüt Kurt(Türkiye Yüksek İhtisas Hastanesi), İbrahim C. Haznedaroğlu(Hacettepe University), Murat Kekilli(Gazi University), Meral Akdoğan(Türkiye Yüksek İhtisas Hastanesi), Mehmet Arhan(Türkiye Yüksek İhtisas Hastanesi), İbrahi̇m Koral Önal(Türkiye Yüksek İhtisas Hastanesi), Erkin Öztaş(Türkiye Yüksek İhtisas Hastanesi), Abdurrahim Sayılır(Türkiye Yüksek İhtisas Hastanesi)
Cited by 58
Related Papers
Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)
|Hepatology|2014|165
Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis
|Clinics and Research in Hepatology and Gastroenterology|2011|117
Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis
|Digestive and Liver Disease|2009|91
Hemostatic Efficacy of Ankaferd Blood Stopper® in a Swine Bleeding Model
|Medical Principles and Practice|2009|86